Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John F Thompson

Showing results (441-450 of 569) with videos related to

Pageof 57
Sort By:
Melanoma Research|October 18, 2014
Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma ModuleJulie B Winstanley, Teresa E Young, Frances M Boyle, et al.
JAMA Network Open|April 19, 2023
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With MelanomaJames R Miller, Serigne N Lo, Mehdi Nosrati, et al.
The Journal of Pathology. Clinical Research|April 19, 2020
Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic valueRaymond Barnhill, Pieter-Jan van Dam, Peter Vermeulen, et al.
JAMA Surgery|January 10, 2024
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node StatusRoger Olofsson Bagge, Rasmus Mikiver, Michael A Marchetti, et al.
Journal of the American College of Surgeons|February 20, 2017
Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity SarcomaJohn E Mullinax, Hidde M Kroon, John F Thompson, et al.
Nature Communications|December 3, 2014
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanomaGeorgina V Long, Carina Fung, Alexander M Menzies, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2025
Nodal radioactivity after lymphoscintigraphy as a guide to sentinel node-positivity in melanoma patientsJohn F Thompson, Roger F Uren, Kevin London, et al.
International Journal of Molecular Sciences|October 13, 2021
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick MelanomasCanan Güvenç, Asier Antoranz, Anna Szumera-Ciećkiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2022
Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patientsMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damageVictoria J Mar, Stephen Q Wong, Jason Li, et al.
Pageof 57

Showing results (441-450 of 569) with videos related to

Sort By:
Pageof 57
Melanoma Research|October 18, 2014
Cross-cultural development of a quality-of-life measure for patients with melanoma: phase 3 testing of an EORTC Melanoma ModuleJulie B Winstanley, Teresa E Young, Frances M Boyle, et al.
JAMA Network Open|April 19, 2023
Improving Selection for Sentinel Lymph Node Biopsy Among Patients With MelanomaJames R Miller, Serigne N Lo, Mehdi Nosrati, et al.
The Journal of Pathology. Clinical Research|April 19, 2020
Replacement and desmoplastic histopathological growth patterns in cutaneous melanoma liver metastases: frequency, characteristics, and robust prognostic valueRaymond Barnhill, Pieter-Jan van Dam, Peter Vermeulen, et al.
JAMA Surgery|January 10, 2024
Population-Based Validation of the MIA and MSKCC Tools for Predicting Sentinel Lymph Node StatusRoger Olofsson Bagge, Rasmus Mikiver, Michael A Marchetti, et al.
Journal of the American College of Surgeons|February 20, 2017
Isolated Limb Infusion as a Limb Salvage Strategy for Locally Advanced Extremity SarcomaJohn E Mullinax, Hidde M Kroon, John F Thompson, et al.
Nature Communications|December 3, 2014
Increased MAPK reactivation in early resistance to dabrafenib/trametinib combination therapy of BRAF-mutant metastatic melanomaGeorgina V Long, Carina Fung, Alexander M Menzies, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|July 4, 2025
Nodal radioactivity after lymphoscintigraphy as a guide to sentinel node-positivity in melanoma patientsJohn F Thompson, Roger F Uren, Kevin London, et al.
International Journal of Molecular Sciences|October 13, 2021
Road to Metastasis: The TWEAK Pathway as a Discriminant between Metastasizing and Non-Metastasizing Thick MelanomasCanan Güvenç, Asier Antoranz, Anna Szumera-Ciećkiewicz, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2022
Effect of the time interval between melanoma diagnosis and sentinel node biopsy on the size of metastatic tumour deposits in node-positive patientsMary-Ann El Sharouni, Richard A Scolyer, Carla H van Gils, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 9, 2013
BRAF/NRAS wild-type melanomas have a high mutation load correlating with histologic and molecular signatures of UV damageVictoria J Mar, Stephen Q Wong, Jason Li, et al.
Pageof 57